A Review of In Vitro Antimicrobial Activities of Carbazole and its
Derivative From 2014 to 2022
-
Published:2023-01
Issue:4
Volume:21
Page:
-
ISSN:2211-3525
-
Container-title:Anti-Infective Agents
-
language:en
-
Short-container-title:AIA
Author:
Kumar Nitin1, Sharma Shalini1, Nirmal Puneet1
Affiliation:
1. Sunder Deep Pharmacy College (SDPC), NH-9(24), Delhi Hapur Road, Dasna, Ghaziabad, Uttar Pradesh 201002, India
Abstract
Abstract:
A large number of antibiotics are easily accessible for the treatment of various micro-bial infections. However, antibiotic resistance has become a major concern to public health across the globe. Carbazole derivatives are present in carbazomycins, an unprecedented class of antibiotics showing potential antibacterial activities. As reported in the literature, carbazole de-rivatives also possess significant antimicrobial activities against bacterial resistance, such as Methicillin Resistant Staphylococcus aureus (MRSA). The antimicrobial profile of carbazole derivatives has been achieved through various bacterial pathways. Carbazole hybrids based on the multi-target direct ligand (MTDL) approach were also extensively studied as they exhibited significant antibacterial activities. This article reviews antimicrobial potential, docking analysis, and structure-activity relationship (SAR) studies of carbazole and its derivatives against tested bacterial strains from 2014 to 2022. This review can also be helpful for investigators in the de-sign and development of new molecules based on carbazole structure against various resistant bacterial infections.
Publisher
Bentham Science Publishers Ltd.
Reference84 articles.
1. Addla D.; Wen S.Q.; Gao W.W.; Maddili S.K.; Zhang L.; Zhou C.H.; Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents. MedChemComm 2016,7(10),1988-1994 2. Zawadzka K.; Felczak A.; Głowacka I.E.; Piotrowska D.G.; Lisowska K.; Evaluation of the Antimicrobial Potential and Toxicity of a Newly Synthesised 4-(4-(Benzylamino)butoxy)-9H-carbazole. Int J Mol Sci 2021,22(23),12796 3. Fernández L.; Cima-Cabal M.D.; Duarte A.C.; Rodriguez A.; García P.; García-Suárez M.M.; Developing diagnostic and therapeutic approaches to bacterial infections for a new era: Implications of globalization. Antibiotics 2020,9(12),916 4. Butler M.S.; Gigante V.; Sati H.; Paulin S.; Al-Sulaiman L.; Rex J.H.; Fernandes P.; Arias C.A.; Paul M.; Thwaites G.E.; Czaplewski L.; Alm R.A.; Lienhardt C.; Spigelman M.; Silver L.L.; Ohmagari N.; Kozlov R.; Harbarth S.; Beyer P.; Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: Despite progress, more action is needed. Antimicrob Agents Chemother 2022,66(3),e01991-e21 5. Murray C.J.L.; Ikuta K.S.; Sharara F.; Swetschinski L.; Robles Aguilar G.; Gray A.; Han C.; Bisignano C.; Rao P.; Wool E.; Johnson S.C.; Browne A.J.; Chipeta M.G.; Fell F.; Hackett S.; Haines-Woodhouse G.; Kashef Hamadani B.H.; Kumaran E.A.P.; McManigal B.; Achalapong S.; Agarwal R.; Akech S.; Albertson S.; Amuasi J.; Andrews J.; Aravkin A.; Ashley E.; Babin F-X.; Bailey F.; Baker S.; Basnyat B.; Bekker A.; Bender R.; Berkley J.A.; Bethou A.; Bielicki J.; Boonkasidecha S.; Bukosia J.; Carvalheiro C.; Castañeda-Orjuela C.; Chansamouth V.; Chaurasia S.; Chiurchiù S.; Chowdhury F.; Clotaire Donatien R.; Cook A.J.; Cooper B.; Cressey T.R.; Cri-ollo-Mora, E.; Cunningham, M.; Darboe, S.; Day, N.P.J.; De Luca, M.; Dokova, K.; Dramowski, A.; Dunachie, S.J.; Duong Bich, T.; Eck-manns, T.; Eibach, D.; Emami, A.; Feasey, N.; Fisher-Pearson, N.; Forrest, K.; Garcia, C.; Garrett, D.; Gastmeier, P.; Giref, A.Z.; Greer, R.C.; Gupta, V.; Haller, S.; Haselbeck, A.; Hay, S.I.; Holm, M.; Hopkins, S.; Hsia, Y.; Iregbu, K.C.; Jacobs, J.; Jarovsky, D.; Javanmardi, F.; Jen-ney, A.W.J.; Khorana, M.; Khusuwan, S.; Kissoon, N.; Kobeissi, E.; Kostyanev, T.; Krapp, F.; Krumkamp, R.; Kumar, A.; Kyu, H.H.; Lim, C.; Lim, K.; Limmathurotsakul, D.; Loftus, M.J.; Lunn, M.; Ma, J.; Manoharan, A.; Marks, F.; May, J.; Mayxay, M.; Mturi, N.; Munera-Huertas, T.; Musicha, P.; Musila, L.A.; Mussi-Pinhata, M.M.; Naidu, R.N.; Nakamura, T.; Nanavati, R.; Nangia, S.; Newton, P.; Ngoun, C.; Novotney, A.; Nwakanma, D.; Obiero, C.W.; Ochoa, T.J.; Olivas-Martinez, A.; Olliaro, P.; Ooko, E.; Ortiz-Brizuela, E.; Ounchanum, P.; Pak, G.D.; Paredes, J.L.; Peleg, A.Y.; Perrone, C.; Phe, T.; Phommasone, K.; Plakkal, N.; Ponce-de-Leon, A.; Raad, M.; Ramdin, T.; Rattanavong, S.; Riddell, A.; Roberts, T.; Robotham, J.V.; Roca, A.; Rosenthal, V.D.; Rudd, K.E.; Russell, N.; Sader, H.S.; Saengchan, W.; Schnall, J.; Scott, J.A.G.; Seekaew, S.; Sharland, M.; Shivamallappa, M.; Sifuentes-Osornio, J.; Simpson, A.J.; Steenkeste, N.; Stewardson, A.J.; Stoeva, T.; Tasak, N.; Thaiprakong, A.; Thwaites, G.; Tigoi, C.; Turner, C.; Turner, P.; van Doorn, H.R.; Velaphi, S.; Vongpradith, A.; Vongsouvath, M.; Vu, H.; Walsh, T.; Walson, J.L.; Waner, S.; Wangrangsimakul, T.; Wannapinij, P.; Wozniak, T.; Young Sharma, T.E.M.W.; Yu, K.C.; Zheng, P.; Sartorius, B.; Lopez, A.D.; Stergachis, A.; Moore, C.; Dolecek, C.; Naghavi, M. Global burden of bacterial antimicrobial re-sistance in 2019: A systematic analysis. Lancet 2022,399(10325),629-655
|
|